Clincosm LogoSign in Get a demo

advanced malignant neoplasm

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Tumor Trial in Changsha, Chengdu (TQB3912 tablets)

Not yet recruiting
  • Advanced Malignant Neoplasm
  • TQB3912 tablets
  • Changsha, Hunan, China
  • +1 more
Aug 10, 2023

Advanced Malignant Tumor Trial in Beijing ([ Lu-177]-Catalase)

Recruiting
  • Advanced Malignant Neoplasm
  • [ Lu-177]-Catalase
  • Beijing, Beijing, China
    Zhi Yang
Aug 2, 2023

Advanced Malignant Tumor Trial in China (TQB2103 for injection)

Not yet recruiting
  • Advanced Malignant Neoplasm
  • TQB2103 for injection
  • Zhengzhou, Henan, China
  • +3 more
May 19, 2023

Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

Not yet recruiting
  • Relapse
  • +7 more
  • Visakhapatnam, Andhra Pradesh, India
  • +5 more
May 7, 2023

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +2 more
  • Laboratory Biomarker Analysis
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Advanced Malignant Tumor, Caregiver, Physician Trial in Houston (Informational Intervention, Questionnaire Administration)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +2 more
  • Informational Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Advanced Malignant Tumor, Delirium, Locally Advanced Malignant Tumor Trial in Houston (Chlorpromazine, Haloperidol,

Active, not recruiting
Has Results
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Financial Distress in Advanced Cancer Patients

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Medical Chart Review
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced Malignant Tumor Trial in Shanghai (Intravenous Infusion)

Recruiting
  • Advanced Malignant Neoplasm
  • Intravenous Infusion
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
May 5, 2022

Advanced Malignant Tumor, Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Caregiver Burden, Quality of Life, and Symptom Distress at

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Mar 2, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Advanced Malignant Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial in Worldwide (DCC-3014)

Recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Palo Alto, California
  • +23 more
Dec 21, 2021

Advanced Malignant Tumor Trial in Chengdu (QLF31907)

Recruiting
  • Advanced Malignant Neoplasm
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital
Dec 8, 2021

Advanced Malignant Tumor Trial in Seattle (Communication Intervention, Questionnaire Administration)

Terminated
  • Advanced Malignant Neoplasm
  • Communication Intervention
  • Questionnaire Administration
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 10, 2021

Advanced Malignant Tumor Trial in Spain, United States (KO-947)

Terminated
  • Advanced Malignant Neoplasm
  • Rochester, Minnesota
  • +4 more
Sep 16, 2021

Advanced Malignant Tumor, Locally Advanced Malignant Tumor Trial in Philadelphia (Counseling, Genetic Counseling, Genetic

Completed
  • Advanced Malignant Neoplasm
  • Locally Advanced Malignant Neoplasm
  • Counseling
  • +4 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 30, 2021

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Anakinra
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Advanced Malignant Tumor, Pain Trial in Houston (device, procedure, other)

Withdrawn
  • Advanced Malignant Neoplasm
  • Pain
  • Macy Catheter
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 12, 2020